25th Mar 2021 11:28
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.
----------
AIM - WINNERS
----------
Tandem Group, up 14% at 653.60 pence, 12-month range 113.26p-669p. The sports equipment distributor says 2020 pretax profit was GBP4.0 million, up 60% from GBP2.5 million in 2019 on revenue of GBP37.1 million, down 4.6% from GBP38.8 million in 2019. Declares final dividend of 5.50p per share, up from 5.04p in 2019. Looking ahead, says it has made an encouraging start to 2021 and is optimistic about the outlook.
----------
Oncimmune Holdings, up 8.3% at 185.78p, 12-month range 43.25p-222p. The immunodiagnostics company will raise GBP9.0 million from a placing of 5.0 million shares at 180p. Oncimmune conducting the fund raise to invest in ImmunoINSIGHTS business. Placing price represents a premium of 5.0% to closing price of 171.5p on Wednesday.
----------
AIM - LOSERS
----------
Genedrive, down 27% at 84.75p, 12-month range 11.07p-302.60p. The molecular diagnostics firm swings to a first half pretax profit of GBP621,000 from a GBP3.3 million loss a year before on revenue of GBP355,000, down from GBP627,000. Says it continues to experience delays in gaining the key regulatory approvals from the US FDA, WHO and in India. Company is focusing on larger commercial opportunities in the Covid-19 space and expects progression from strategy in the coming months.
----------
Starcom, down 16% at 0.80p, 12-month range 0.72p-1.34p. The remote tracking systems firm posts 2020 operating loss of USD1.8 million, widened from USD706,000 loss in 2019 on revenue down to USD5.0 million from USD6.8 million in 2019.
----------
SpaceandPeople, down 14% at 8.65p, 12-month range 3.7p-19.6p. The promotional and brand experience specialist says trading during the second half of 2020 remained extremely challenging as further lockdowns in the UK and Germany affected the ability to operate. SpaceandPeople expects to swing to 2020 pretax loss of around GBP2.5 million from profit of GBP10,000 in 2019.
----------
Ebiquity, down 9.6% at 26.5p, 12-month range 17.1p-33p. The marketing and media consultancy says annual results reflect effects of Covid-19 pandemic on global advertising and client budgets. Ebiquity says 2020 pretax loss narrows to GBP3.9 million from GBP5.7 million in 2019 on revenue GBP55.9 million, down from GBP68.1 million. Ebiquity not proposing dividend for 2020 due to Covid-19 uncertainty.
----------
By Arvind Bhunjun; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
EbiquityGenedriveOncimmuneStar EnergyTandem GroupSpaceandPeople